Magaldrate and Simethicone Oral Suspension

This is a preview of
USP-NF/PF content.

Subscriber?
Access here! Not a subscriber?
Learn more!

» Magaldrate and Simethicone Oral Suspension contains not less than 90.0 percent and not more than 110.0 percent of the labeled amount of magaldrate [Al₅Mg₁₀(OH)₃₁(SO₄)₂], and an amount of polydimethylsiloxane [–(CH₃)₂SiO–] _n that is not less than 85.0 percent and not more than 115.0 percent of the labeled amount of simethicone.

USP REFERENCE STANDARDS FOR PURCHASE

USP Polydimethylsiloxane RS
USP Magaldrate RS

This is a preview of
USP-NF/PF content.

Subscriber?
Access here!Not a subscriber?
Learn more!